Drugmaker Pfizer said Wednesday it has begun a late-stage human trial of an influenza vaccine that uses the pioneering messenger-RNA deployed widely for the coronavirus.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Pfizer starts late-stage trial of mRNA-based flu vaccinePfizer Inc said on Wednesday it had started a late-stage U.S. trial of an influenza vaccine involving 25,000 patients, among the first such studies for a messenger RNA flu shot.
Consulte Mais informação »
Harris County Public Health Has Pfizer Omicron Booster ShotsThe new COVID-19 vaccination booster shots are now available and Harris County Public Health began giving them out Monday. The bivalent Pfizer COVID-19 booster vaccine authorized for individuals 12 years and older, is available to eligible residents and is administered in a single dose. The new vaccine is designed to protect...
Consulte Mais informação »
The Most Common Side Effects Of The New Bivalent COVID BoosterHere's what you can expect when you get the Pfizer or Moderna vaccine and how you can ease any symptoms.
Consulte Mais informação »
EU watchdog approves vaccine targeting new Omicron sub-variantsEU's medicine watchdog approves vaccine specifically targeting the new and contagious BA.4 and BA.5 types of the Omicron variant amid fears of a new wave of Covid-19 winter infections
Consulte Mais informação »